Cargando…
Upscaling vaccine manufacturing capacity - key bottlenecks and lessons learned
The COVID-19 pandemic put enormous pressure on the vaccine production chain as billions of vaccines had to be produced in the shortest timeframe possible. Vaccine production chains struggled to keep up with demand, resulting in disruptions and production delays. This study aimed to make an inventory...
Autores principales: | Feddema, Jelle J., Fernald, Kenneth D.S., Schikan, Hans G.C.P., van de Burgwal, Linda H.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239264/ https://www.ncbi.nlm.nih.gov/pubmed/37277250 http://dx.doi.org/10.1016/j.vaccine.2023.05.027 |
Ejemplares similares
-
The Upscale Manufacture of Chondrocytes for Allogeneic Cartilage Therapies
por: Hulme, Charlotte H., et al.
Publicado: (2023) -
mRNA vaccines manufacturing: Challenges and bottlenecks
por: Rosa, Sara Sousa, et al.
Publicado: (2021) -
Lower Respiratory Tract Infection Trends in East and
South-East Asia: In the Light of Economic and Health Care
Development
por: Feddema, Jelle J., et al.
Publicado: (2021) -
Consolidating and Upscaling Molecular Research Capacity in Nigeria: On Who's Account?
por: Chukwudi, Chinwe Uzoma
Publicado: (2022) -
Plasmid manufacture is the bottleneck of the genetic medicine revolution
por: Ohlson, Jonny
Publicado: (2020)